Juha O. Rinne is first author of a newly published Phase II study
Juha O. Rinne from at LINK Medical’s Clinical Trial Unit in Turku is first author of a newly published Phase II study investigating at Orion Pharma’s ORM-12741 in Alzheimer’s disease. Our CTU participated as a site in this multicenter trial. The study adds important evidence to an area where new treatment options are still needed.
